Personal CFO Solutions’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$300K Sell
3,305
-70
-2% -$6.42K 0.04% 378
2025
Q4
$303K Sell
3,375
-101
-3% -$9.58K 0.05% 366
2025
Q3
$342K Buy
3,476
+505
+17% +$50K 0.06% 307
2025
Q2
$271K Sell
2,971
-375
-11% -$36.3K 0.05% 359
2025
Q1
$379K Buy
3,346
+660
+25% +$70.6K 0.08% 260
2024
Q4
$284K Buy
2,686
+72
+3% +$7.72K 0.06% 342
2024
Q3
$282K Buy
2,614
+478
+22% +$52.2K 0.04% 444
2024
Q2
$232K Sell
2,136
-37
-2% -$4.36K 0.04% 457
2024
Q1
$287K Buy
2,173
+102
+5% +$12.7K 0.04% 408
2023
Q4
$252K Sell
2,071
-1,123
-35% -$125K 0.04% 419
2023
Q3
$359K Buy
3,194
+21
+0.7% +$2.67K 0.07% 281
2023
Q2
$462K Buy
3,173
+1,414
+80% +$192K 0.09% 220
2023
Q1
$227K Buy
+1,759
New +$221K 0.05% 407

Other funds holding ZBH

Personal CFO Solutions's ZBH Position: Q1 2026 in Review

Personal CFO Solutions reduced its Zimmer Biomet (ZBH) stake by 2.1% in Q1 2026, selling an estimated $6.42K and leaving 3,305 shares worth $300K. The position accounts for 0.04% of the portfolio, ranked #378.

Personal CFO Solutions first reported a position in ZBH in Q1 2023 and has held it in 13 quarters since. The position peaked at $462K in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Personal CFO Solutions held 3,305 shares of Zimmer Biomet worth $300K as of Q1 2026.
  • Personal CFO Solutions sold 70 Zimmer Biomet shares in Q1 2026, an estimated $6.42K.
  • Zimmer Biomet made up 0.04% of Personal CFO Solutions's portfolio in Q1 2026, its #378 holding.
  • Personal CFO Solutions first reported a position in Zimmer Biomet in Q1 2023 and has held it in 13 quarters since.
  • Personal CFO Solutions's Zimmer Biomet position peaked at $462K in Q2 2023.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Personal CFO Solutions's 13F filing for Q1 2026, filed 30 Apr 2026.